Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

PCOD mainly affects young women, causing symptoms like irregular periods and weight gain, with mixed success from lifestyle changes and medication.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Hormonal therapies are safe and effective for treating adult women's acne.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

New treatments aim to improve thin endometrium to help more couples with infertility.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.